Marijuana

Canada Cannabis Stocks

Canada Cannabis Stocks

Canada Cannabis Stocks could take off with the news that marijuana could protect humans from Covid-19. Let’s take a look at 3 Canadian stocks that should be on every traders radar.

Aurora Cannabis (NASDAQ: ACB)

The $2 billion Aurora Cannabis ACB in recent quarters it has been putting up attractive growth numbers with medical cannabis. In its last fiscal quarter medical cannabis revenue rose 42% year over year, as its international medical cannabis sales boosted growth, soaring 562%.

Aurora’s consumer division is growing too, rising 25% last quarter compared to the same period in the previous year. That division is responsible for things like vapes, edibles and concentrates directly to the customer.

Canada Cannabis Stocks such as ACB are really looking good.

Canopy Growth Corporation (NASDAQ:CGC)

The largest of the Canadian cannabis  stocks, Canopy Growth CGC is worth more than $12 billion.

CGC owns several different brands, and it doesn’t just sell marijuana: the company sells CBD, oil, concentrates and capsules.

CGC established operations and distribution network could serve them well upon a move intothe US market. CGC is just waiting for more favorable regulations.

Canada Cannabis Stocks such as Canopy Growth Corporation should be placed on your watchlist.

Cronos Group (NASDAQ:CRON)

Cronos Group CRON reported the highest revenue growth of any major Canadian cannabis stock last quarter, 133% in the fourth quarter of 2020.

Growth was driven by blockbuster expansion in non-U.S. markets, where sales nearly tripled, going from $4.6 million to $13.5 million year over year.

While growth rates this high are certainly hard to find, CRON stock is by no means priced cheaply, with its $3.65 billion market cap representing a price-sales ratio of about 75.

Canada Cannabis Stocks are on the rise, make sure you follow Cronos Group CRON, Canopy Growth CGC & Aurora Cannabis ACB.

read more
Cannabis Prevented Covid: What Stocks to Follow

Cannabis Prevented Covid: What Stocks to Follow

We’ve been dealing with Covid-19, it seems like for years and it has impacted almost everyone we know. Some folks have lost income, some have lost the most precious thing, loved ones. Our country is also divided on the basics of this pandemic. However, there might be a light at the end of the tunnel with a surprising,but well known, hero. Marijuana, cannabis, wacky tobacky, whatever you call it is showing clinical research to prevent Covid-19. Cannabis Prevented Covid: what stocks to follow so we can make some money.

Cannabis prevented Covid infection in a study released this week and it has Wall Street in a frenzy! Marijuana stocks have been taking a beating over the last year so this is a much needed clinical research for those cannabis traders.

 

CRBP

 

Cannabis Prevented Covid, now what?

There is an incredible article by Bloomberg, here. As we start looking at the impact of this news, we should start researching Cannabis stocks to see if we can capitalize on this amazing green rush that could take place. Cannabis Prevented Covid: what stocks to follow below.

3 Cannabis Stocks To Watch

1. Ticker Corp Name Exchange: CRBP Corbus Pharmaceuticals Holdings, Inc. OTC

Summary: Corbus is committed to connecting innovation to our purpose of improving lives by developing new medicines that target inflammation, fibrosis, metabolism and immuno-oncology, by building upon our underlying expertise in immunology. Corbus’ current pipeline includes small molecules that activate or inhibit the endocannabinoid system and anti-integrin monoclonal antibodies that block activation of TGFβ.

2. Ticker Corp Name Exchange: CGC Canopy Growth Corp NASDAQ

Summary: Canopy Growth (TSX:WEED, NASDAQ:CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. 

Leveraging consumer insights and innovation, we offer product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. 

Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany.

3. Ticker Corp Name Exchange: TLRY Tilray Brands NASDAQ

Summary: Tilray, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing.

Happy trading and enjoy our future articles and breaking alerts by signing up below.

 

CGC

read more
Marijuana Company of America MCOA Intro

Marijuana Company of America MCOA Intro

Marijuana Company of America MCOA is looking very interesting, take a look!

MCOA

Marijuana Company of America Company Summary

Company Name:  Marijuana Company of America

Ticker: MCOA

Exchange: NASDAQ

Website: https://www.marijuanacompanyofamerica.com/

MCOA Company Summary

Marijuana Company of America (MCOA) invests in the cannabis sector directly. The company’s operations include C-Distro, one of the THC, Hemp & CBD cannabis industries fastest growing distribution companies, and hempsmart™, a Premium CBD company. The company’s core mission is to leverage its experience, and access to capital to identify and invest in acquisitions with unique growth potential.

Why did Marijuana Company of America go up?

Dec. 15, 2021

Announced that it has recently completed the acquisition of VBF Brands, Inc. (“VBF”) a marijuana cultivator and distributor based in Salinas, California. VBF was previously a wholly-owned subsidiary of Sunset Island Group, Inc. (OTC: SIGO).

MCOA 1 Day Chart

MCOA

MCOA Technical Analysis

MCOA has been on a major slide for over a month. It appears that it is consolidating and it may be ready to move once we see a double confirmation. We just got one this week the next confirmation will be $.0017, keep a keen eye on that price target. It could take off once it crosses it.

MCOA

read more
Curaleaf Holdings CURLF bounce?

Curaleaf Holdings CURLF bounce?

Curaleaf Holdings CURLF is looking poised for a great run, put it on your watchlist today! Let’s take a closer look at CURLF.

Company Name: Curaleaf Holdings

Ticker: CURLF

Exchange: OTC

Website: https://ir.curaleaf.com

Curaleaf Holdings CURLF Company Summary:

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption.

As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets.

In the United States, Curaleaf currently operates in 23 states with 117 dispensaries, 25 cultivation sites, and employs over 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. 

Why do I like CURLF?

Dec. 28, 2021 Curaleaf Holdings, Inc. announced that it has entered into a definitive agreement to acquire Bloom Dispensaries (“Bloom”), a vertically integrated, single state cannabis operator in Arizona in an all cash transaction valued at approximately US$211 million. The Transaction is expected to close in January 2022, subject to customary approvals and conditions.

Consequently, Now that I covered the news, let’s look at CURLF 1 Month Chart

CURLF 5 Day Chart

Curaleaf Holdings CURLF Technical Analysis

Curaleaf Holdings has reversed it’s bearish trend with plenty of confirmation. The acquisition of Bloom Dispensaries by Curaleaf Holdings, Inc. is a big deal. The market is reacting to it in a positive way.

Beyond the Bloom Dispensaries deal, the 1 Month chart shows a clear reversal and the 5 day confirms it as well. Put it on your watchlist today, I like this stock! If you trade this stock, place stop losses at $8.75 to protect your investment!

read more
INSD Instadose Pharma Corp. – Company Snapshot

INSD Instadose Pharma Corp. – Company Snapshot

Company Snapshot

Company Name: Instadose Pharma Corp. (INSD)

Ticker: INSD

Exchange: OTC

Website: https://www.instadosepharma.com/ 

Industry: Cannabis 

Company Summary:

Canada-based Instadose Pharma was established in July 2017 as an extension of a ground-breaking deal with the Democratic Republic of the Congo (DRC). The Canadian company became the first to obtain a full license to cultivate medical cannabis in the DRC and it is the only one with permission to export this product from the African country for international sale and distribution.   The company has since expanded its operations through joint partnerships with other countries which include Southern Africa, Mexico, North Macedonia and Portugal.  Instadose Pharma continues to build relationships and joint ventures with other countries around the world.

INSD’s product: 

Medicinal Cannabis BioMass – Instadose Pharma is committed to the highest level of standards when it comes to production and distribution of cannabis to be used for extraction purposes.

5 Day Chart

The stock consolidated after a 1,000% explosion! The $36 price per share as seen below is a critical support level that I would keep your eye on, but it seems to be consolidating and could make another move. However, what goes up must come down and a 1,000% in the last 6 weeks is really, really up!

Daily Chart

Only one down day in a month! It appears that this could be a campaign, as you see the three distinct buying cycles in late September, Mid October and the last three days. Based on the historical pattern, I would imagine this should be the end of the run today or tomorrow. 

Technical Summary

This stock is thinly traded with low trading volume and I would expect it to be extremely volatile after the 300% run over the last month. 

Conclusion

1,000% gains over the last 6 weeks, consolidation over the last 5 days, I would be very concerned because what must go up must come down. However, this has a lot of attention on it and I would keep an eye open for a pullback and correction, then maybe jump on it!

read more
Spotlite360 Secures Agreement with One of Colorado’s Longest-Established Cannabis Dispensary Operators to Facilitate Planned Multi-State Expansion

Spotlite360 Secures Agreement with One of Colorado’s Longest-Established Cannabis Dispensary Operators to Facilitate Planned Multi-State Expansion

Read original article here.

DENVER and VANCOUVER, British Columbia, Aug. 11, 2021 (GLOBE NEWSWIRE) — SPOTLITE360 TECHNOLOGIES, INC. (“Spotlite360” or the “Company”) (CSE: LITE) (OTC: SPLTF) (Frankfurt: 87A) is pleased to announce that it has entered into a master terms agreement (the “Agreement”) with Peak Dispensary (“Peak”), a cannabis dispensary operator with locations in Denver and Sedgwick, Colorado, to develop scopes of work for the integration of the Company’s suite of technologies (the “Spotlite360 Technologies”) into Peak’s systems as part of its business objectives. At this time, Peak is planning an expansion into at least five new states which are likely to present complex regulatory challenges in each jurisdiction. Additionally, the ability of the Spotlite360 Technologies to track provenance of goods in the supply chain could prove instrumental to its ability to maintain product and brand integrity in the course of such expansions.

 

Shortly before announcing a licensing agreement with a Colorado-based hemp manufacturer in a July 29, 2021 press release, the Company released a video presentation by its President James Greenwell detailing the applications of the Spotlite360 Technologies in the cannabis industry. In a CNBC op-ed last month, technology was recognized as the driver of growth opportunities in the cannabis industry to fill gaps left by traditional enterprise solutions. Although such technologies are suitable for businesses that are subject to lower regulatory burdens with less expansive inventories (e.g., a restaurant with 30 menu items), cannabis dispensaries in the United States are regulated to a much greater degree and commonly stock hundreds or thousands of product varieties. For instance, although cannabis edibles can carry more than 134 different attributes such as strains and ingredients, there is no normalized data collection process for this type of information1. Through a combination of blockchain and Internet-of-Things (“IoT”) capabilities, the Spotlite360 Technologies can allow for this data to be gathered efficiently and transmitted proactively to suit the increasingly sophisticated needs of the cannabis industry.

Under the scope of work contemplated in the Agreement, Peak intends to leverage the Spotlite360 Technologies to improve visibility into the movement of its products through the supply chain both to create new business value and to diligently comply with the unique regulations in each new state in which it plans to operate. Peak has also contract grown more than 50 unique strains of cannabis, several of which are award-winning, and has recognized the benefits of using IoT sensors (e.g., for temperature and humidity) for the purposes of optimizing product quality and preventing losses from damage or mishandling.

As an early-stage player in the cannabis industry with the fourth dispensary license ever issued in the state of Colorado, Peak believes that the Spotlite360 Technologies can play a role in fortifying its reputation as a world-class purveyor of cannabis products. The visitor traffic to Peak’s Denver location in April of 2015 on the days surrounding the annual April 20 cannabis culture celebration (popularly known as “420”) was highlighted in a Business section article of the Denver Post later that year, which included 82 buses and 17 limousines in a four-day period2. Furthermore, Peak has enjoyed considerable media attention from several well-known outlets, which can be viewed on Peak’s Media webpage: http://peakmj.com/media/

A photo accompanying this announcement is available athttps://www.globenewswire.com/NewsRoom/AttachmentNg/74e92a47-8f6c-4c43-8287-fc5bc63066a3

In the third episode of “In My City: Denver”, a series produced by HipHopDX (a channel owned by Warner Music Group), Peak was featured as an iconic contributor to Denver’s music scene, with patronage from high-profile recording artists. This episode can be viewed by clicking the thumbnail above or by clicking here.

Readers using news aggregation services may be unable to view the media above. Please access SEDAR for a version of this press release containing all published media.

Spotlite360 President James Greenwell commented, “Accountability is the name of the game in the cannabis industry in 2021. In markets across the country, industry players are facing all kinds of questions from customers, suppliers, and regulators, and it is mandatory to have the right answers. As evidenced by last month’s CNBC article, weaknesses in legacy technologies for users in the cannabis industry are coming to the surface given the space’s unique nuances compared to other sectors. Blockchain and IoT technologies can each contribute to providing unprecedented value to firms in the cannabis industry, particularly in out-of-state expansions such as those presently being planned by Peak. We are pleased to have entered into this agreement with such an established and well-regarded cannabis dispensary operator here in our home state, and we look forward to maximizing their potential through the use of the Spotlite360 Technologies.”

Sources

1 – https://www.cnbc.com/2021/07/07/op-ed-technology-is-driving-the-cannabis-industrys-biggest-growth-opportunity-.html

2 – https://www.denverpost.com/2015/10/30/legal-to-legit-colorado-marijuana-industry-sheds-stoner-stigma/

On behalf of the Board of Directors of the Company,

Spotlite360 Technologies Inc.

“James Greenwell”

James Greenwell, President

For more information about Spotlite360, please visit: http://spotlite360.com

Charles LeeInvestor Relations and Media Inquiries+1 (720) 830-6120[email protected]

THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.

About Spotlite360 Technologies Inc.

Spotlite360 is a logistics technologies solutions provider unlocking value, opportunities, and efficiencies for all participants in a supply chain. Building upon existing applications of IoT technologies, distributed ledgers, and machine learning, Spotlite360 endeavours to set new standards of transparency, integrity, and sustainability in the pharmaceutical, healthcare, and agriculture industries. As regulators across the globe begin to impose new tracing and accountability requirements for the protection of consumers (e.g., DSCSA and FSMA from the U.S. Food and Drug Administration), the need for reliable, cost-effective, and versatile tracking technology is expected to grow considerably. Spotlite360’s flagship SaaS solution has been engineered to seamlessly track the movement of a product by integrating with systems of all major stakeholders in a supply chain ranging from the raw materials to the hands of the end consumer. With a primary objective of onboarding new clients in 2021, Spotlite360 plans to explore innovative use cases for its proprietary stack of technologies which could transform logistics workflows in some of the world’s largest industries.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation, with respect to the Company. The forward-looking information included in this news release is not based on historical facts, but rather on the expectations of the Company’s management regarding the future growth of the Resulting Issuer, its results of operations, performance, business prospects, and opportunities. This news release uses words such as “will”, “expects”, “anticipates”, “intends”, “plans”, “believes”, “estimates”, or similar expressions to identify forward-looking information. Such forward-looking information reflects the current beliefs of the Company’s management, based on information currently available to them.

This forward-looking information includes, among other things, statements relating to: the intentions, plans and future actions of the Company; statements relating to the business and future activities of the Company; anticipated developments in operations of the Company; market position, ability to compete, and future financial or operating performance of the Company; the timing and amount of funding required to execute the business plans of the Company; capital expenditures of the Company; the effect on the Company, of any changes to existing or new legislation or policy or government regulation; the length of time required to obtain permits, certifications and approvals; the availability of labour; estimated budgets; currency fluctuations; requirements for additional capital; limitations on insurance coverage; the timing and possible outcome of regulatory and permitting matters; goals; strategies; future growth; the adequacy of financial resources; our expectations regarding revenues, expenses and anticipated cash needs.

In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Forward-looking statements are based on certain assumptions and analyses made by the Company in light of the experience and perception of historical trends, current conditions, and expected future developments and other factors it believes are appropriate, and are subject to risks and uncertainties. Although the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and there can be no assurance that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties, and assumptions, prospective investors should not place undue reliance on these forward-looking statements. Whether actual results, performance, or achievements will conform to the expectations and predictions of the Company is subject to a number of known and unknown risks, uncertainties, assumptions, and other factors, including those listed in the Company’s non-offering prospectus dated May 26, 2021.

If any of these risks or uncertainties materialize, or if assumptions underlying the forward-looking statements prove incorrect, actual results might vary materially from those anticipated in the forward-looking statements. Information contained in forward-looking statements in this news release is provided as of the date of this news release, and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information or future events or results, except to the extent required by applicable securities laws. Accordingly, potential investors should not place undue reliance on forward-looking statements or the information contained in those statements.

All of the forward-looking information contained in this news release is expressly qualified by the foregoing cautionary statements.

Statement Regarding Third-Party Investor Relations Firms

Disclosures relating to investor relations firms retained by Spotlite360 Technologies Inc. can be found under the Company’s profile on http://sedar.com.

Disclaimer

Small Cap Exclusive is owned and operated by JBN PARTNERS LLC, which is a US based corporation. We are paid advertisers, also known as stock touts or stock promoters, who disseminate favorable information (this “Article”) about publicly traded companies (the “Profiled Issuers”).

We publish the Information on our website, smallcapexclusive.com/ and in newsletters, text message alerts, audio services, live interviews, featured “research” reports, on message boards and in email communications for specific time periods that are agreed upon between us and the Profiled Issuer and / or third party paying us. Our publication of the Information is known as a “Campaign”. This information may be sent to potential investors at different times that are minutes, hours, days or even weeks apart. Typically, the trading volume and price of a Profiled Issuer’s securities increases after the information is provided to the first group of investors. Therefore, the later an investor receives the Information, the more likely it is that he will suffer trading losses if they purchase the securities of a Profiled Issuer late in a Campaign. We are paid to advertise the Profiled Issuers, SpotLite360. Small Cap Exclusive has been hired by SpotLite360 for a period beginning on July 10, 2021 for 3 months to publicly disseminate information about SpotLite360 via website and email. We have been compensated $50,000 USD. We will update any changes to our compensation.

Read full disclaimer here.

read more
KushCo Holdings (OTC:KSHB) reports Quarterly results: What Next?

KushCo Holdings (OTC:KSHB) reports Quarterly results: What Next?

One of the cannabis companies which had a remarkably bad time in 2019 was KushCo Holdings (OTC:KSHB), and it seems that the company’s troubles are not over yet. Health-related panic about vaping had hit KushCo pretty hard last year, and this past Wednesday, the company announced its fiscal second-quarter results following the closure of markets. 

The company is also facing troubles from the mayhem unleashed by the coronavirus pandemic. Here is a look at some of the highlights from the company’s fiscal second-quarter results for 2020. 

Earnings Review

In the second quarter, the company’s net revenues came in at $30.14 million, which reflects a year on year fall of 14%. While that piled on the misery for KushCo, it should be noted that the figure scraped past analysts’ estimates of $30.13 million. The losses widened significantly to $44.4 million for the quarter, which worked out to losses $0.40 a share. In the year-ago period, the company’s net losses stood at $8.9 million, which worked out to losses of $0.10 per share, and that reflects a major rise in the company’s losses. The decline in the vaping business has been cited as one of the key reasons behind the loss.

[thrive_leads id=’8276′]

In November last year, the company had launched its hemp trading business, but until now, it has not been able to boost its earnings. KushCo also has a considerable presence in California, and despite the state declaring cannabis as essential business, its sales took a hit as more people ordered the product. One of the brighter points from the earnings report was that the company managed to boost its sales in some of its markets. Sales rose in Michigan, Massachusetts, Canada, and Illinois. The company’s Chief Executive Officer stated that investors could accept more stable revenues in the coming quarters and went on to say that KushCo could also produce positive EBITDA earnings soon.

read more
White Label Liquid Inc. (OTCMKTS:WLAB) Stock Gains Momentum, What To Do?

White Label Liquid Inc. (OTCMKTS:WLAB) Stock Gains Momentum, What To Do?

White Label Liquid, Inc. (OTCMKTS:WLAB) stock is going well this year with a gain of over 75% since the beginning of this year. Let’s analyze the recent developments about the company.

Florida based hemp-based CBD oil company White Label Liquid has established itself as one of the leading suppliers of customer mad CBD oil products to a range of big-ticket companies over the past few years.

White Label Liquid has considerable production capabilities and can churn out as many as 50,000 units per day. In addition to the largest cannabis companies, it also supplies to dealers, distributors, and stores all across the world.

[thrive_leads id=’8276′]

Financial Results

On 11 April this year, the company announced its financial results for 2018 and the numbers were highly encouraging. The company generated revenues of $7,006,110 and it topped its 2017 revenues of $5 million by a significant margin. The rise reflected a year on year rise of 250% and demonstrated the fact that the company has continued to grow at a fast clip.

However, in this regard, it is also necessary to keep in mind that White Label has continued to raise its range of offerings and back on 25 March this year, the company announced that it is going further expand its range of CBD oils. The move is particularly important since CBD oils are the fastest growing niche in the hemp market and White Label is determined to be one of the biggest players in that segment.

New products will include CBD infused olive oils, honey tinctures and much more. The CBD oils market is expected to be worth $22 billion at some point and White Label wants to capture a major chunk of it.

Varied Line Of CBD Products

Earlier on in March, on the 19th to price, it came to light that White Label provides the most varied line of CBD products to its clients. At this point in time, the CBD market has grown into a behemoth with a customer base of 10 million. White Label continues to be the main supplier for most resellers, who take White Label’s products and then sell it under their own label.

read more
Origin House (CNSX:OH) Stock Is Up 108% Since Its Listing on CSE

Origin House (CNSX:OH) Stock Is Up 108% Since Its Listing on CSE

Origin House (CNSX:OH)‘s stock is up over 108% from its listing price of $5.40 on May 18, 2018. The stock closed at $11.27 CAD on May 17, 2019. Since its listing, OH’s stock has been moving within in a range of $3.18-11.40.

Origin House’s (recently renamed from CannaRoyalty Corporation) investors have had to with longer since its last quarterly report in November to know how the company performed in Q4 2018. Earlier this mornith, Origin House (OTCMKTS: ORHOF) announced its Q4 2018 financial results which shows the company has had tremendous revenue growth.

Q4 2018 results and milestones

The company began by offering cannabis operators with funding through royalty streaming deals. However the company has diversified and they now focus on the California cannabis brands as well as distribution operations although they still make considerable revenue from the royalty streaming business. Although the company didn’t give a breakdown of the Q4 revenue according to segments close to 92% of the revenue coming from cannabis operations in California. The rest of the revenue resulted from interests, royalties and services.

[thrive_leads id=’8276′]

Origin House’s Q4 2018 revenue grew 19% sequentially from Q3’s total revenue of $4.93 million. The growth in revenue was a result of Origin House’s California cannabis distribution business as well as the addition of new product line of cannabis brands.

Origin House agreements and deals

In Q4 2018 the company completed acquisition of 180 Smoke a Canadian based vape retailer. Similarly there are other notable developments that the company achieved in the quarter such as deals with Viola Brans, Henry’s Original and Kurvana. The company also entered strategic financing agreements with Utopia cannabis and Humboldt’s Finest Farms.

Perhaps the biggest development was plans by Cresco Labs (OTCMKTS: CRLBF) to acquire Origin House in one of the largest cannabis company all-stock transaction.

In a statement, Origin House president Afzal Hassan indicated that they were delighted about how the company performed last year. Most of the year was spent in developing and creating premium brands and a distribution platform in California.

Origin House CEO, Marc Lustig said that the Cresco labs acquisition was a result of the company’s aggressive creation of premium brands and a distribution platform in California. The combined entity will dominate the US with over 50 brands and 725 dispensaries.

read more